Education
About Us
Working with TipRanks
Follow Us
Jagsonpal Pharmaceuticals Ltd. (IN:JAGSNPHARM)
:JAGSNPHARM
Summary of all the Indicators
Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Moving Averages Convergence Divergence (MACD) indicator is -3.59, suggesting Jagsonpal Pharmaceuticals Ltd. is a Buy.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 20-Day exponential moving average is 238.75, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹214.45, making it a Sell.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 50-Day exponential moving average is 241.13, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹214.45, making it a Sell.
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Pivot Points
Classic
228.30
229.85
232.40
233.95
236.50
238.05
240.60
Fibonacci
229.85
231.42
232.38
233.95
235.52
236.48
238.05
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Moving Averages
MA5
233.17Sell
230.34Sell
MA10
239.31Sell
235.34Sell
MA20
239.78Sell
238.75Sell
MA50
248.84Sell
241.13Sell
MA100
236.31Sell
238.13Sell
MA200
233.41Sell
233.76Sell
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 10-Day exponential moving average is 235.34, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹214.45, making it a Sell.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 100-Day exponential moving average is 238.13, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹214.45, making it a Sell.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) stock price is ₹214.45 and Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 50-day simple moving average is 248.84, creating a Sell signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) stock price is ₹214.45 and Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 100-day simple moving average is 236.31, creating a Sell signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) stock price is ₹214.45 and Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 200-day simple moving average is 233.41, creating a Sell signal.
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Technical Indicators
RSI (14)
30.97
Neutral
STOCH (9,6)
7.19
Buy
STOCHRSI (14)
7.19
Buy
MACD (12,26)
-3.59
Buy
ADX (14)
14.16
Buy
Williams %R
-94.42
Buy
CCI (14)
-319.39
Buy
ATR (14)
10.73
-
Ultimate Oscillator
28.06
Sell
ROC
-10.04
Sell
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Relative Strength Index (RSI) is 30.97, creating a Neutral signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Trend Strength Indicator (ADX) is 14.16, creating a Buy signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Commodity Channel Index (CCI) is -319.39, creating a Buy signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Price Rate of Change (ROC) is -10.04, creating a Sell signal.
FAQ
Is JAGSNPHARM a Buy, Hold, or Sell?
Based on JAGSNPHARM’s technical indicators, JAGSNPHARM is a Sell.
What is JAGSNPHARM’s RSI (14)?
JAGSNPHARM’s RSI (14) is 30.97, which suggests JAGSNPHARM is a Neutral.
What is JAGSNPHARM’s MACD?
JAGSNPHARM’s MACD is -3.59, which suggests JAGSNPHARM is a Buy.
What is JAGSNPHARM’s 5-day moving average?
JAGSNPHARM’s 5-day moving average is 233.17, which suggests JAGSNPHARM is a Sell.
What is JAGSNPHARM’s 20-day moving average?
JAGSNPHARM 20-day moving average is 239.78, which suggests JAGSNPHARM is a Sell.
What is JAGSNPHARM’s 50-day moving average?
JAGSNPHARM’s 50-day moving average is 248.84, which suggests JAGSNPHARM is a Sell.
What is JAGSNPHARM’s 200-day moving average?
JAGSNPHARM’s 200-day moving average is 233.41, which suggests JAGSNPHARM is a Sell.
What is JAGSNPHARM’s Williams % R (14)?
JAGSNPHARM’s Williams % R (14) is -94.42, which suggests JAGSNPHARM is a Buy.
What is JAGSNPHARM’s CCI (14)?
JAGSNPHARM’s CCI (14) is -319.39, which suggests JAGSNPHARM is a Buy.
What is the share price of Jagsonpal Pharmaceuticals Ltd.?